The link you have chosen leads to a site maintained by a third party over whom Novartis has no control. As such, Novartis makes no representation as to the accuracy or any other aspect of the information on this site.
The clinical use in these resources may not be consistent with the approved indications for Tyverb. The information in these resources is not country-specific and may contain information that is outside the approved indications where you practice. Please contact your local Novartis representative for the latest product information specific to your country.
This is an international site for Tyverb® (lapatinib) and is intended for Healthcare Professionals outside the US.
TYVERB® (lapatinib) is approved in three indications in multiple countries around the world. 60 countries